scholarly article | Q13442814 |
P50 | author | Rennolds S. Ostrom | Q55601888 |
P2093 | author name string | Fengying Li | |
Xiaoqiu Liu | |||
Louisa Balazs | |||
Shu Qiang Sun | |||
Joseph Kaminsky | |||
Muthusamy Thangavel | |||
P2860 | cites work | Cellular and molecular mechanisms of fibrosis | Q24648892 |
Inhibition of adenylyl cyclase isoforms V and VI by various Gbetagamma subunits | Q27867715 | ||
Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy | Q28200083 | ||
Angiotensin II enhances adenylyl cyclase signaling via Ca2+/calmodulin. Gq-Gs cross-talk regulates collagen production in cardiac fibroblasts | Q28569021 | ||
cAMP inhibits transforming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and Smad signaling in cardiac fibroblasts | Q28571517 | ||
Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. | Q30837023 | ||
Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality | Q31920931 | ||
Mechanisms of myofibroblast activity and phenotypic modulation. | Q33691240 | ||
Regulation and role of adenylyl cyclase isoforms | Q33939373 | ||
Stoichiometry and compartmentation in G protein-coupled receptor signaling: implications for therapeutic interventions involving G(s). | Q33971828 | ||
Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase | Q34019710 | ||
Compartmentation of G protein-coupled signaling pathways in cardiac myocytes | Q34192792 | ||
Overexpression of Gs alpha protein in the hearts of transgenic mice | Q34208757 | ||
Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. | Q34211740 | ||
Early role of Fsp1 in epithelial-mesenchymal transformation | Q34445512 | ||
The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology | Q35047674 | ||
Bleomycin-induced pulmonary fibrosis in hamsters. An alveolar macrophage product increases fibroblast prostaglandin E2 and cyclic adenosine monophosphate and suppresses fibroblast proliferation and collagen production | Q35208313 | ||
Mechanisms of pulmonary fibrosis | Q35640281 | ||
Increased expression of adenylylcyclase type VI proportionately increases beta-adrenergic receptor-stimulated production of cAMP in neonatal rat cardiac myocytes | Q35785891 | ||
Role of endothelin in fibrosis and anti-fibrotic potential of bosentan | Q36132271 | ||
Simple method of estimating severity of pulmonary fibrosis on a numerical scale | Q36451354 | ||
The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals | Q36609104 | ||
Adenylyl cyclase type 6 overexpression selectively enhances beta-adrenergic and prostacyclin receptor-mediated inhibition of cardiac fibroblast function because of colocalization in lipid rafts. | Q37150683 | ||
Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes | Q37362466 | ||
Adenylyl cyclase--A-kinase anchoring protein complexes: the next dimension in cAMP signaling | Q37415827 | ||
Identification of a novel cis-acting element for fibroblast-specific transcription of the FSP1 gene. | Q38334819 | ||
Prostaglandin E2 inhibits specific lung fibroblast functions via selective actions of PKA and Epac-1. | Q39990887 | ||
Fibrotic lung fibroblasts show blunted inhibition by cAMP due to deficient cAMP response element-binding protein phosphorylation. | Q40389196 | ||
cAMP-elevating agents and adenylyl cyclase overexpression promote an antifibrotic phenotype in pulmonary fibroblasts. | Q40568376 | ||
PDE4 inhibitors attenuate fibroblast chemotaxis and contraction of native collagen gels | Q40729067 | ||
Attenuation of pulmonary fibrosis in mice by aminophylline | Q41244195 | ||
Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy | Q41674006 | ||
Proliferation of rat and human lung fibroblasts following exposure to prostaglandin E2. | Q41734846 | ||
Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression | Q43606201 | ||
Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase. | Q43726525 | ||
Adenylyl cyclase increases survival in cardiomyopathy | Q43984501 | ||
The effect of PGE2 on the activation of quiescent lung fibroblasts | Q44096122 | ||
Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation. | Q44435135 | ||
Common genomic response in different mouse models of beta-adrenergic-induced cardiomyopathy | Q44659637 | ||
Propranolol-induced elevation of pulmonary collagen | Q44998803 | ||
Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor | Q45872754 | ||
16,16-Dimethyl prostaglandin E2 efficacy on prevention and protection from bleomycin-induced lung injury and fibrosis | Q46211980 | ||
Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice | Q46697034 | ||
COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis | Q46941026 | ||
Ca2+-sensitive adenylyl cyclases, key integrators of cellular signalling | Q48470679 | ||
Idiopathic Pulmonary Fibrosis | Q56804123 | ||
The differential effect of prostaglandin E2 on transforming growth factor-beta and insulin-induced collagen formation in lung fibroblasts | Q69542548 | ||
Correlation between pulmonary fibrosis and the lung pressure-volume curve | Q71618454 | ||
Beta-adrenergic agonists attenuate fibroblast-mediated contraction of released collagen gels | Q71897925 | ||
Nitric oxide selectively inhibits adenylyl cyclase isoforms 5 and 6 | Q73713525 | ||
Decreased prostaglandin E2 synthesis by lung fibroblasts isolated from rats with bleomycin-induced lung fibrosis | Q77869046 | ||
Characterization of fibroblast-specific protein 1 in pulmonary fibrosis | Q81196614 | ||
P433 | issue | 6 | |
P921 | main subject | pulmonary fibrosis | Q32446 |
P304 | page(s) | L819-29 | |
P577 | publication date | 2010-03-26 | |
P1433 | published in | American Journal of Physiology - Lung Cellular and Molecular Physiology | Q4352992 |
P1476 | title | Fibroblast-specific expression of AC6 enhances beta-adrenergic and prostacyclin signaling and blunts bleomycin-induced pulmonary fibrosis | |
P478 | volume | 298 |
Q91755679 | Activation of the prostaglandin E2 EP2 receptor attenuates renal fibrosis in unilateral ureteral obstructed mice and human kidney slices |
Q92458275 | Glucocorticoids rapidly activate cAMP production via Gαs to initiate non-genomic signaling that contributes to one-third of their canonical genomic effects |
Q34441135 | Hydrogel scaffolds as in vitro models to study fibroblast activation in wound healing and disease |
Q39112299 | Inhibition of TRPM7 channels prevents proliferation and differentiation of human lung fibroblasts |
Q38247635 | Novel insights into TRPM7 function in fibrotic diseases: a potential therapeutic target |
Q42454314 | PDE2-mediated cAMP hydrolysis accelerates cardiac fibroblast to myofibroblast conversion and is antagonized by exogenous activation of cGMP signaling pathways. |
Q36159130 | cAMP and Epac in the regulation of tissue fibrosis. |
Search more.